American Society of Clinical Oncology (ASCO) shared a post LinkedIn:

“Mark your calendars for our upcoming virtual Grand Rounds to explore the use of Precision Medicine through the TAPUR Study. The TAPUR Study is an ongoing Clinical Trial conducted by ASCO that examines the potential of using targeted therapies outside of their approved use to benefit patients with later-stage cancer, leading to increased options for personalised therapies.
When: Monday, May 6, at 2:00 PM ET
Where: Online
Who: Open to all members of the oncology community

Featured speakers include:

• Richard Schilsky, TAPUR Study Principal Investigator.
• Jens Rueter, Medical Director of the Maine Cancer Genomics Initiative.
• Janet Freeman-Daily, Lung cancer patient and advocate; President of The ROS1ders.”

Additional information.
Source: ASCO/LinkedIn